Skip to content

Quantifying Myofascial Dysfunction in Post-Stroke Pain

Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05762679
Acronym
Myofascial
Enrollment
46
Registered
2023-03-10
Start date
2023-02-28
Completion date
2024-05-24
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Dysfunction

Keywords

Glycosaminoglycan, Hyaluronic acid, Post stroke shoulder pain

Brief summary

The purpose of this study is to quantify the extent of GlycosAminoGlycan/Hyaluronic Acid (GAG/HA) accumulation using T1rho (T1ρ) MRI in the paretic versus non-paretic shoulder rotator muscles, and correlate the T1ρ Magnetic Resonance Imaging (MRI) measurements with US echo texture measurements to develop a clinic-friendly tool to infer the extent of HA accumulation; and to distinguish between latent versus active Post Stroke Shoulder Pain (PSSP) using ultrasound (US) shear strain mapping of the same muscles on the paretic side compared with the non-paretic side.

Detailed description

Shoulder pain is extremely common after stroke and occurs in 30-70% of patients. Chronic post stroke shoulder pain (PSSP) contributes to depression, interferes with motor recovery, and decreases quality of life. Although PSSP is thought to be caused by damage to the myofascial tissues around the shoulder joint, the pathophysiology of myofascial dysfunction and pain in PSSP has not been elucidated, leading to missed opportunities for early diagnosis, and variable success with pain management. The accumulation of HA in muscle and its fascia can cause myofascial dysfunction. HA is a GAG and a chief constituent of the extracellular matrix of muscle. In physiologic quantities, it functions as a lubricant and a viscoelastic shock absorber, enabling force transmission during muscle contraction and stretch. Reduced joint mobility and spasticity can result in focal accumulation and alteration of HA in muscle, leading to the development of taut bands, dysfunctional gliding of deep fascia and muscle layers, Reduced Range of Motion (ROM), and pain. Muscle HA concentrations can be imaged using T1ρ MRI, and myofascial dysfunction can be assessed using echo texture analysis and shear strain mapping on quantitative US, which may serve as useful biomarkers to elucidate the pathophysiology of myofascial dysfunction in PSSP.

Interventions

DIAGNOSTIC_TESTImaging

Phase 1 is an imaging biomarker study.

Sponsors

National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH
New York University
CollaboratorOTHER
George Mason University
CollaboratorOTHER
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Hemiparesis from Ischemic or Hemorrhagic Stroke * 4-120 months post-stroke with Hemiparesis since the incidence and intensity of PSSP * Show a difference of more than 10 degrees of passive ER-ROM between non-paretic and paretic shoulders with or without pain * Able to provide informed consent and comply with testing protocols

Exclusion criteria

* Received treatment for spasticity with Botulinum Toxin or Intrathecal Baclofen within the past three months * Have another neurologic condition that may affect motor response (e.g. Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS)) * Have a contraindication to MRI (claustrophobia, magnetic pacemakers and clips) * Have non-musculoskeletal PSSP such as only central pain or Chronic Regional Pain Syndrome (CRPS) * Have a complicated medical condition, or significant injury to either upper limb.

Design outcomes

Primary

MeasureTime frameDescription
Ultrasound Shear Strain Percentage Between Paretic vs. Non-paretic MusclesBaselineComparison of ultrasound shear strain between pectoralis major and pectoralis minor muscles on the paretic and non-paretic sides in patients with post stroke shoulder pain.
T1 Rho MRI Relaxation Time of Shoulder External Rotator (Milliseconds)BaselineComparison of T1rho (T1ρ) MRI relaxation time of infraspinatus muscles on the paretic and non-paretic sides of patients with post stroke shoulder pain.
T1 Rho MRI Relaxation Time of Shoulder Internal Rotator (Milliseconds)BaselineComparison of T1rho (T1ρ) MRI relaxation time of pectoralis major muscles on paretic and non-paretic shoulders in patients with post stroke shoulder pain.
Ultrasound Shear Strain Percentage Between Paretic vs. Non-paretic Side in Patients With High Severity Post Stroke Shoulder PainBaselineComparison of ultrasound shear strain between pectoralis major and minor muscles on the paretic side compared with the non-paretic side in patients with high severity post stroke shoulder pain

Countries

United States

Participant flow

Recruitment details

All participants were enrolled at Johns Hopkins Hospital.

Pre-assignment details

Of 46 consented participants, 42 met inclusion criteria.

Participants by arm

ArmCount
Paretic - Low Severity
Low severity PSSP defined as focal palpable nodules that may be tender on palpation with pain rating of \< 5/10 when combined with the hand-behind-neck (HBN) maneuver. Imaging: Phase 1 is an imaging biomarker study.
22
Paretic - High Severity
High severity PSSP is defined as focal palpable nodules that are tender on palpation, reproducing the pain, and eliciting a pain rating of \>= 5/10 when combined with the hand-behind-neck (HBN) maneuver. Imaging: Phase 1 is an imaging biomarker study.
24
Total46

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyNo analyzable imaging data1
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicParetic - Low SeverityParetic - High SeverityTotal
Age, Continuous59.59 years
STANDARD_DEVIATION 12.21
59.67 years
STANDARD_DEVIATION 9.56
59.63 years
STANDARD_DEVIATION 10.78
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants0 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
20 Participants24 Participants44 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants3 Participants5 Participants
Race (NIH/OMB)
Black or African American
8 Participants14 Participants22 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants1 Participants3 Participants
Race (NIH/OMB)
White
10 Participants6 Participants16 Participants
Sex: Female, Male
Female
7 Participants14 Participants21 Participants
Sex: Female, Male
Male
15 Participants10 Participants25 Participants
Time since stroke49.64 Months
STANDARD_DEVIATION 45.55
36.38 Months
STANDARD_DEVIATION 32.69
42.72 Months
STANDARD_DEVIATION 39.49

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 42
other
Total, other adverse events
0 / 42
serious
Total, serious adverse events
0 / 42

Outcome results

Primary

T1 Rho MRI Relaxation Time of Shoulder External Rotator (Milliseconds)

Comparison of T1rho (T1ρ) MRI relaxation time of infraspinatus muscles on the paretic and non-paretic sides of patients with post stroke shoulder pain.

Time frame: Baseline

Population: MRI data were collected from 31 participants to compare paretic side with non-paretic side. Four participants were excluded based on pre-specified MRI criteria not being met. Five participants were excluded from analysis based on not meeting pre-specified criteria for pain.

ArmMeasureValue (MEAN)Dispersion
PareticT1 Rho MRI Relaxation Time of Shoulder External Rotator (Milliseconds)29.09 millisecondsStandard Deviation 3.02
Non-PareticT1 Rho MRI Relaxation Time of Shoulder External Rotator (Milliseconds)27.15 millisecondsStandard Deviation 2.2
Primary

T1 Rho MRI Relaxation Time of Shoulder Internal Rotator (Milliseconds)

Comparison of T1rho (T1ρ) MRI relaxation time of pectoralis major muscles on paretic and non-paretic shoulders in patients with post stroke shoulder pain.

Time frame: Baseline

Population: MRI data was collected from 31 participants to compare paretic side with non-paretic side. Four participants were excluded based on pre-specified MRI criteria not being met. Five participants were excluded from analysis based on not meeting pre-specified criteria for pain.

ArmMeasureValue (MEAN)Dispersion
PareticT1 Rho MRI Relaxation Time of Shoulder Internal Rotator (Milliseconds)31.83 millisecondsStandard Deviation 3.54
Non-PareticT1 Rho MRI Relaxation Time of Shoulder Internal Rotator (Milliseconds)30.96 millisecondsStandard Deviation 3.6
Primary

Ultrasound Shear Strain Percentage Between Paretic vs. Non-paretic Muscles

Comparison of ultrasound shear strain between pectoralis major and pectoralis minor muscles on the paretic and non-paretic sides in patients with post stroke shoulder pain.

Time frame: Baseline

Population: Ultrasound data were collected from 33 participants to compare paretic side with non-paretic side. Two were excluded from analysis based on lack of image clarity. Five participants were excluded from analysis based on not meeting pre-specified criteria for pain.

ArmMeasureValue (MEAN)Dispersion
PareticUltrasound Shear Strain Percentage Between Paretic vs. Non-paretic Muscles46.54 Shear strain percentageStandard Deviation 19.81
Non-PareticUltrasound Shear Strain Percentage Between Paretic vs. Non-paretic Muscles35.37 Shear strain percentageStandard Deviation 13.95
Primary

Ultrasound Shear Strain Percentage Between Paretic vs. Non-paretic Side in Patients With High Severity Post Stroke Shoulder Pain

Comparison of ultrasound shear strain between pectoralis major and minor muscles on the paretic side compared with the non-paretic side in patients with high severity post stroke shoulder pain

Time frame: Baseline

Population: Ultrasound data were collected from 18/33 participants with high severity PSSP to compare paretic side with non-paretic side.

ArmMeasureValue (MEAN)Dispersion
PareticUltrasound Shear Strain Percentage Between Paretic vs. Non-paretic Side in Patients With High Severity Post Stroke Shoulder Pain47.46 Shear strain percentageStandard Deviation 20.76
Non-PareticUltrasound Shear Strain Percentage Between Paretic vs. Non-paretic Side in Patients With High Severity Post Stroke Shoulder Pain35.67 Shear strain percentageStandard Deviation 12.86

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026